{"id":"W2555978778","doi":"10.1182/blood.v120.21.4053.4053","title":"Treatment Outcomes with Pomalidomide (POM) in Combination with Low-Dose Dexamethasone (LoDex) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) and Del(17p13) and/or t(4;14)(p16;q32) Cytogenetic Abnormalities Who Have Received Prior Therapy with Lenalidomide (LEN) and Bortezomib (BORT)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Pomalidomide; Medicine; Tolerability; Internal medicine; Multiple myeloma; Lenalidomide; Bortezomib; Oncology; Adverse effect; Population; Expanded access; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007570938,0.0005727008,0.00105778,0.0002743696,0.0003190083,0.0008347867,0.000473339,0.0007704414,0.001747154],"category_scores_gemma":[0.001047771,0.000276647,0.001302721,0.0003837515,0.0006352724,0.00068533,0.0005162639,0.001681588,0.0002987461],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009545957,"about_ca_system_score_gemma":0.0006888887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008680852,"about_ca_topic_score_gemma":0.002014384,"domain_scores_codex":[0.9996194,0.0001685741,0.00003388097,0.00006604251,0.00003588967,0.00007629698],"domain_scores_gemma":[0.9992421,0.00013026,0.0001822432,0.00002968976,0.00002065827,0.0003951728],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8557663,0.02461718,0.04066496,0.0003131236,0.001049741,0.0002697163,0.0002769854,0.00296948,0.009908669,0.0001380485,0.00110483,0.06292096],"study_design_scores_gemma":[0.2337964,0.6544449,0.101388,0.00007550622,0.001497158,0.0004306778,0.0002031685,0.0027485,0.002843978,0.000331933,0.002183003,0.00005668611],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984212,0.0007114166,0.00005659761,0.0001098541,0.00002521728,0.0001185529,0.0001998211,0.000006103885,0.0003511802],"genre_scores_gemma":[0.9983695,0.0003561081,0.0002057602,0.0001797058,0.00005995631,0.0001543801,0.0004143777,0.000002584183,0.0002575913],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001747154,"threshold_uncertainty_score":0.006926119,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01879581665067745,"score_gpt":0.2603826589457445,"score_spread":0.241586842295067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}